Growth Metrics

ADC Therapeutics (ADCT) Convertible Debt: 2022

  • ADC Therapeutics' Convertible Debt was N/A to -$118,304 in Q4 2022 from the same period last year, while for Dec 2022 it was -$118,304, marking a year-over-year change of. This contributed to the annual value of -$118,304 for FY2022, which is N/A change from last year.
  • Latest data reveals that ADC Therapeutics reported Convertible Debt of -$118,304 as of Q4 2022, which was down 0.20% from -$118,070 recorded in Q3 2022.
  • ADC Therapeutics' 5-year Convertible Debt high stood at -$118,070 for Q3 2022, and its period low was -$118,304 during Q4 2022.
  • Its 1-year average for Convertible Debt is -$118,187, with a median of -$118,187 in 2022.